First Trust NYSE Arca Biotechnology Index Fund (FBT) Short Interest Ratio & Short Volume

Short interest is the volume of First Trust NYSE Arca Biotechnology Index Fund shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 5,000 shares of FBT short. Learn More on First Trust NYSE Arca Biotechnology Index Fund's current short interest.

First Trust NYSE Arca Biotechnology Index Fund saw a decrease in short interest in May. As of May 15th, there was short interest totaling 5,000 shares, a decrease of 64.8% from the previous total of 14,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to First Trust NYSE Arca Biotechnology Index Fund: First Trust Health Care AlphaDEX Fund (0.14%), Invesco S&P 500 Equal Weight Health Care ETF (1.31%), VanEck Pharmaceutical ETF (41.19%), iShares U.S. Pharmaceuticals ETF (4.51%), Direxion Daily S&P Biotech Bull 3x Shares (18.41%), VanEck Biotech ETF (0.29%), Invesco Pharmaceuticals ETF (0.11%), Invesco Biotechnology & Genome ETF (0.04%), SPDR S&P Health Care Equipment ETF (0.55%), SPDR S&P Pharmaceuticals ETF (49.86%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

Short selling FBT is an investing strategy that aims to generate trading profit from First Trust NYSE Arca Biotechnology Index Fund as its price is falling. FBT shares are trading down $1.27 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for First Trust NYSE Arca Biotechnology Index Fund occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FBT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FBT, twice per month. The most recent reporting period available is May, 15 2025.